Combatting COVID-19: Innovative therapeutic and diagnostic solutions for rapid detection and prevention
With the emergence of global pandemic, the company focused on finding therapeutic and diagnostic solutions to relieve the burden of transmission of the COVID-19 virus. In addition to the introduction of certain therapies used in the COVID-19 protocols, the company became marketing authorization holder of innovative test kits, for the rapid detection COVID-19 infection, the first of their kind to be approved for self-testing in the market. The company introduced a brand of BCG vaccine, which is used for the treatment of existing bladder tumours and for the prophylaxis of recurrence. This immunotherapy is applied after transurethral resection of superficial tumors with the aim of preventing recurrence. Therapy is very deficient in the country, and irregular application of this therapy can increase the chance of disease recurrence.